Latest investment trends were presented by BIOTECH Insight at the start of the German Equity Forum
C4X Discovery Holdings plc has exclusively licenced its NRF2 Activator programme to AstraZeneca and has got an upfront payment of $2m.
Munich-based immunooncology specialist CatalYm GmbH wants to use €50m from a Series C financing round to advance its anti-GDF15 antibody to Phase II development.
Cellular agriculture company Cultimate Foods UG has got a pre-seed funding led by Big Idea Ventures, ProVeg International and Realum.cloud.
Biotech start-up Cradle BV has raised €5.4m in seed financing to design cell-factories with AI and scale bioprocesses much faster and cheaper.
Microbial casein maker Standing Ovation SA has inked an exklusive collaboration with Bel Group, one of France’s biggest cheese-makers to bring its vegan cheese to the market.
EpiEndo Pharmaceuticals ehf got the green light for a Phase IIa COPD trial with its non-anbibiotic macrolide EP395
Danish Novo Nordisk Foundation has invested in Plant2Food, a new open innovation hub for researchers and companies to develop plant-based foods.
German Neotiv GmbH hat closed a €10m seed financing to speed-up product launch of its early diagnosis app for Alzheimer’s disease
Jolt Capital contributed $20m to the BC Platforms’ data footprint expansion on November 8th.